Article PDF
References
Belardinelli L, Linden J, Berne RM : The cardiac effects of adenosine. Prog Cardiovasc Dis 1989; 32: 73–97.
Olsson RA, Pearson JD : Cardiovascular purinocepotrs. Physiol Rev 1990; 70: 761–845.
Sparks HV Jr, Bardenheuer H : Regulation of adenosine formation by heart. Circ Res 1986; 58: 193–201.
Camm AJ, Garratt CJ : Adenosine and supraventricular tachycardia. N Engl J Med 1991; 325: 1621–1629.
DiMarco JP, Sellers TD, Berne RM, West GA, Belardinelli L : Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 1983; 68: 1254–1263.
Hori M, Kitakaze M : Adenosine, the heart, and coronary circulation. Hypertension 1991; 18: 565–574.
Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T : Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implication for myocardial salvage. Circulation 1993; 87: 208–215.
Asakura M, Asanuma H, Kim J, et al: Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens Res 2007; 30: 781–787.
Loh E, Rebbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW : Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 1999; 99: 1422–1425.
Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M : Plasma adenosine levels increase in patients with chronic heart failure. Circulation 1997; 95: 1363–1365.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hisatome, I. Adenosine and Cardioprotection in Chronic Heart Failure: Genes and Protein Expression. Hypertens Res 30, 757–758 (2007). https://doi.org/10.1291/hypres.30.757
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.757
Keywords
This article is cited by
-
Cardiac purinergic signalling in health and disease
Purinergic Signalling (2015)